CoChat

Maternal paracetamol (acetaminophen) use during pregnancy and risk of autism spectrum disorder and attention deficit/hyperactivity disorder in offspring: umbrella review of systematic reviews

Open access

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

Objective: To assess the quality, biases, and validity of evidence on maternal paracetamol (acetaminophen) use during pregnancy and the risk of autism spectrum disorder (referred to as autism) and attention deficit/hyperactivity disorder (ADHD) in offspring. Design: Umbrella review of systematic reviews. Data sources: Medline, Embase, PsycINFO, and the Cochrane Database of Systematic Reviews, along with grey literature, Epistemonikos, and the reference lists of included studies (inception to 30 September 2025). Inclusion criteria: Systematic reviews of randomised trials and cohort, case-control, or cross sectional studies that reported maternal paracetamol use during pregnancy and the diagnosis of autism or ADHD in offspring. Details of the primary studies included in the reviews are reported, including adjustments for key confounders (maternal characteristics, indication for paracetamol use, and familial factors) and unmeasured confounders and ascertainment of outcomes. Results: Nine reviews (40 studies) reporting on autism (six studies) and ADHD (17 studies) in offspring were included. Four reviews undertook meta-analysis. The overlap of primary studies included in the reviews was very high (corrected covered area 23%). The reviews reported a possible to strong association between maternal paracetamol intake and autism or ADHD or both in offspring. Seven of the nine reviews advised caution when interpreting the findings owing to the potential risk of bias and confounding in the included studies. Confidence in the findings of the reviews was low (two reviews) to critically low (seven reviews) based on the AMSTAR 2 (A MeaSurement Tool to Assess Systematic Reviews) criteria. Only one review included studies (n=2) reporting autism and ADHD in offspring that appropriately adjusted for familial factors and unmeasured confounding through sibling controlled analyses. In both studies, the increased risk of autism in offspring (one study, hazard ratio 1.05, 95% confidence interval 1.02 to 1.08) and ADHD (two studies, 1.07, 1.05 to 1.10 and 2.02, 1.17 to 3.25 ) observed in the whole cohort analyses did not persist in sibling controlled analyses for autism (0.98, 0.93 to 1.04) and ADHD (0.98, 0.94 to 1.02 and 1.06, 0.51 to 2.05). Conclusion: Existing evidence does not clearly link maternal paracetamol use during pregnancy with autism or ADHD in offspring. Systematic review registration: PROSPERO CRD420251154052.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj-2025-088141

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Flow chart of review identification process. ADHD=attention deficit/hyperactivity disorder; ASD=autism spectrum disorder
Fig 1 Flow chart of review identification process. ADHD=attention deficit/hyperactivity disorder; ASD=autism spectrum disorderCC BY-NC · PubMed Central
Fig 2 Methodological quality of reviews. Overall confidence in the results of the review are classified: High: Zero or one non-critical weakness: the systematic review provides an accurate and comprehensive summary of the results of the available studies that address the question of interest. Moderate: More than one non-critical weakness: the systematic review has more than one weakness, but no critical flaws. It may provide an accurate summary of the results from the available studies included in the review. Low: One critical flaw with or without non-critical weaknesses: the review has a critical flaw and may not provide an accurate and comprehensive summary of the available studies that address the question of interest. Critically low: More than one critical flaw with or without non-critical weaknesses: the review has more than one critical flaw and should not be relied on to provide an accurate and comprehensive summary of the available studies. Notes: Item 1: The current study rated this as “no” when the review did not include a section that explicitly specified the components of the PICO question. If these components were not stated in the review but were available in the published protocol, the current study rated this item as “yes.” Item 3: The current study rated this item as “no” when the review did not justify the choice of study design(s). If the review merely listed the types of studies to be included, or stated that all types of studies were eligible, it was also rated as “no.” Item 9: Given that the ROBINS-I and ROBINS-E tools are the standard for evaluating risk of bias in non-randomised studies, the use of alternative instruments was rated as “partial yes,” since they do not provide the same level of methodological rigour and comprehensiveness. Item 11: Since one of the conditions for scoring this item as “yes” is either that adjusted data were included in the pooled analysis or that the use of raw data was justified when adjusted data were unavailable, the current study rated this item as “no” when these conditions were not met. Masarwa 2020 is an update of Masarwa 2018. This review focused on unmeasured confounding and provided limited details on the review methodology, stating that the same methods as the previous review were followed. *Critical domains. AMSTAR-2=A MeaSurement Tool to Assess systematic Reviews 2; MA=meta-analysis; PICO=population, intervention, comparison and outcome; RoB=risk of bias; ROBINS-E=Risk Of Bias In Non-randomised Studies-of Exposure; ROBINS-I=Risk Of Bias In Non-randomised Studies-of Interventions
Fig 2 Methodological quality of reviews. Overall confidence in the results of the review are classified: High: Zero or one non-critical weakness: the systematic review provides an accurate and comprehensive summary of the results of the available studies that address the question of interest. Moderate: More than one non-critical weakness: the systematic review has more than one weakness, but no critical flaws. It may provide an accurate summary of the results from the available studies included in the review. Low: One critical flaw with or without non-critical weaknesses: the review has a critical flaw and may not provide an accurate and comprehensive summary of the available studies that address the question of interest. Critically low: More than one critical flaw with or without non-critical weaknesses: the review has more than one critical flaw and should not be relied on to provide an accurate and comprehensive summary of the available studies. Notes: Item 1: The current study rated this as “no” when the review did not include a section that explicitly specified the components of the PICO question. If these components were not stated in the review but were available in the published protocol, the current study rated this item as “yes.” Item 3: The current study rated this item as “no” when the review did not justify the choice of study design(s). If the review merely listed the types of studies to be included, or stated that all types of studies were eligible, it was also rated as “no.” Item 9: Given that the ROBINS-I and ROBINS-E tools are the standard for evaluating risk of bias in non-randomised studies, the use of alternative instruments was rated as “partial yes,” since they do not provide the same level of methodological rigour and comprehensiveness. Item 11: Since one of the conditions for scoring this item as “yes” is either that adjusted data were included in the pooled analysis or that the use of raw data was justified when adjusted data were unavailable, the current study rated this item as “no” when these conditions were not met. Masarwa 2020 is an update of Masarwa 2018. This review focused on unmeasured confounding and provided limited details on the review methodology, stating that the same methods as the previous review were followed. *Critical domains. AMSTAR-2=A MeaSurement Tool to Assess systematic Reviews 2; MA=meta-analysis; PICO=population, intervention, comparison and outcome; RoB=risk of bias; ROBINS-E=Risk Of Bias In Non-randomised Studies-of Exposure; ROBINS-I=Risk Of Bias In Non-randomised Studies-of InterventionsCC BY-NC · PubMed Central
Fig 3 Maternal paracetamol (acetaminophen) use during pregnancy and association with autism spectrum disorder and attention deficit/hyperactivity disorder. An interactive version of this graphic is available at https://public.flourish.studio/visualisation/26019505/
Fig 3 Maternal paracetamol (acetaminophen) use during pregnancy and association with autism spectrum disorder and attention deficit/hyperactivity disorder. An interactive version of this graphic is available at https://public.flourish.studio/visualisation/26019505/CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 39

Metadata

Authors
Sheikh, J., Allotey, J., Sobhy, S., Plana, M. N., Martinez-Barros, H., Naidu, H., Junaid, F., Sofat, R., Mol, B. W., Kenny, L. C., Gladstone, M., Teede, H., Zamora, J., & Thangaratinam, S.
Affiliations
  • University of Liverpool (GB)
  • University of Birmingham (GB)
  • Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain
  • Monash University (AU)
Corresponding author
Thangaratinam, Shakila
Venue
BMJ
Publisher
BMJ
Published
2025-11-09
Volume
391
Pages
e088141
ISSN
1756-1833 (ISSN-L)
OpenAlex
W4416058376
Cited by
33
References
48
Citations by year
2026: 28 · 2025: 5
FWCI
6.32
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc)
  • University of Birmingham Research Portal (University of Birmingham) (publishedVersion, cc-by-nc)
Funders
  • National Institute for Health and Care Research
  • Department of Health and Social Care
  • Instituto de Salud Carlos III
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords
paracetamol, pregnancy, autism spectrum disorder, attention deficit hyperactivity disorder, confounding, risk of bias, AMSTAR 2, umbrella review of systematic reviews, prenatal drug exposure, unmeasured confounding
MeSH terms
Autism Spectrum Disorder, Systematic Reviews as Topic, Acetaminophen, Attention Deficit Disorder with Hyperactivity, Female, Humans, Pregnancy, Prenatal Exposure Delayed Effects, Risk Factors, Analgesics, Non-Narcotic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Maternal paracetamol (acetaminophen) use during pregnancy and risk of autism spectrum disorder and attention deficit/hyperactivity disorder in offspring: umbrella review of systematic reviews. https://app.cochat.ai/papers/10.1136/bmj-2025-088141
The paper
Sheikh, J., Allotey, J., Sobhy, S., Plana, M. N., Martinez-Barros, H., Naidu, H., Junaid, F., Sofat, R., Mol, B. W., Kenny, L. C., Gladstone, M., Teede, H., Zamora, J., & Thangaratinam, S. (2025). Maternal paracetamol (acetaminophen) use during pregnancy and risk of autism spectrum disorder and attention deficit/hyperactivity disorder in offspring: umbrella review of systematic reviews. BMJ. https://doi.org/10.1136/bmj-2025-088141

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.